<document id="DDI-DrugBank.d48">
    <sentence id="DDI-DrugBank.d48.s0" text="Drugs that may increase dasatinib plasma concentrations CYP3A4 Inhibitors: Dasatinib is a CYP3A4 substrate.">
        <entity charOffset="24-32" id="DDI-DrugBank.d48.s0.e0" text="dasatinib" type="drug" />
        <entity charOffset="75-83" id="DDI-DrugBank.d48.s0.e1" text="Dasatinib" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s0.e0" e2="DDI-DrugBank.d48.s0.e1" id="DDI-DrugBank.d48.s0.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s2" text="In patients receiving treatment with SPRYCEL, close monitoring for toxicity and a SPRYCEL dose reduction should be considered if systemic administration of a potent CYP3A4 inhibitor cannot be avoided.">
        <entity charOffset="37-43" id="DDI-DrugBank.d48.s2.e0" text="SPRYCEL" type="brand" />
        <entity charOffset="82-88" id="DDI-DrugBank.d48.s2.e1" text="SPRYCEL" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s2.e0" e2="DDI-DrugBank.d48.s2.e1" id="DDI-DrugBank.d48.s2.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s3" text="Drugs that may decrease dasatinib plasma concentrations CYP3A4 Inducers: Drugs that induce CYP3A4 activity may decrease dasatinib plasma concentrations.">
        <entity charOffset="24-32" id="DDI-DrugBank.d48.s3.e0" text="dasatinib" type="drug" />
        <entity charOffset="120-128" id="DDI-DrugBank.d48.s3.e1" text="dasatinib" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s3.e0" e2="DDI-DrugBank.d48.s3.e1" id="DDI-DrugBank.d48.s3.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s5" text="If SPRYCEL must be administered with a CYP3A4 inducer, a dose increase in SPRYCEL should be considered.">
        <entity charOffset="3-9" id="DDI-DrugBank.d48.s5.e0" text="SPRYCEL" type="brand" />
        <entity charOffset="74-80" id="DDI-DrugBank.d48.s5.e1" text="SPRYCEL" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s5.e0" e2="DDI-DrugBank.d48.s5.e1" id="DDI-DrugBank.d48.s5.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s8" text="Antacids: Nonclinical data demonstrate that the solubility of dasatinib is pH dependent.">
        <entity charOffset="0-7" id="DDI-DrugBank.d48.s8.e0" text="Antacids" type="group" />
        <entity charOffset="62-70" id="DDI-DrugBank.d48.s8.e1" text="dasatinib" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s8.e0" e2="DDI-DrugBank.d48.s8.e1" id="DDI-DrugBank.d48.s8.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s9" text="Simultaneous administration of SPRYCEL with antacids should be avoided.">
        <entity charOffset="31-37" id="DDI-DrugBank.d48.s9.e0" text="SPRYCEL" type="brand" />
        <entity charOffset="44-51" id="DDI-DrugBank.d48.s9.e1" text="antacids" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d48.s9.e0" e2="DDI-DrugBank.d48.s9.e1" id="DDI-DrugBank.d48.s9.p0" type="advise" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s10" text="If antacid therapy is needed, the antacid dose should be administered at least 2 hours prior to or 2 hours after the dose of SPRYCEL.">
        <entity charOffset="3-9" id="DDI-DrugBank.d48.s10.e0" text="antacid" type="group" />
        <entity charOffset="125-131" id="DDI-DrugBank.d48.s10.e1" text="SPRYCEL" type="brand" />
        <pair ddi="true" e1="DDI-DrugBank.d48.s10.e0" e2="DDI-DrugBank.d48.s10.e1" id="DDI-DrugBank.d48.s10.p0" type="advise" />
    </sentence>
    <sentence id="DDI-DrugBank.d48.s14" text="Drugs that may have their plasma concentration altered by dasatinib CYP3A4 Substrates: Dasatinib is a time-dependent inhibitor of CYP3A4.">
        <entity charOffset="58-66" id="DDI-DrugBank.d48.s14.e0" text="dasatinib" type="drug" />
        <entity charOffset="87-95" id="DDI-DrugBank.d48.s14.e1" text="Dasatinib" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d48.s14.e0" e2="DDI-DrugBank.d48.s14.e1" id="DDI-DrugBank.d48.s14.p0" />
    </sentence>
    </document>